Direct to patient: the rocky road to remote drug delivery in clinical trials
While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.
Stay updated with breaking news from Key Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.
Middle East & Africa witnessed a 17.1% drops in IT hiring activity in the pharma industry in December 2021, according to GlobalData’s Job Analytics index
The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this... | February 4, 2022
NorthSea Therapeutics has commenced a Phase I trial of SEFA-6179 in adult subjects, to obtain a preliminary orphan indication to treat IFALD.
The US FDA cleared IND application of Viridian Therapeutics to commence Phase I trial of its antibody VRDN-002 to treat thyroid eye disease.